ALB and breast carcinoma: A retrospective study assessed efficacy and safety of nanoparticle albumin-bound paclitaxel-based chemotherapy (nPBC) and docetaxel-based chemotherapy (DBC) as NAT for breast cancer, revealing that nPBC is correlated with favorable pCR [39].